Logo image of BNXA.CA

BANXA HOLDINGS INC (BNXA.CA) Stock Fundamental Analysis

TSX-V:BNXA - CA06683R1010 - Common Stock

1.22 CAD
-0.06 (-4.69%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

BNXA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 29 industry peers in the Financial Services industry. The financial health of BNXA is average, but there are quite some concerns on its profitability. BNXA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BNXA had negative earnings in the past year.
In the past year BNXA had a positive cash flow from operations.
In the past 5 years BNXA always reported negative net income.
BNXA had a negative operating cash flow in each of the past 5 years.
BNXA.CA Yearly Net Income VS EBIT VS OCF VS FCFBNXA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

The Return On Assets of BNXA (-38.75%) is worse than 93.10% of its industry peers.
Industry RankSector Rank
ROA -38.75%
ROE N/A
ROIC N/A
ROA(3y)-66.12%
ROA(5y)-64.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNXA.CA Yearly ROA, ROE, ROICBNXA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

BNXA has a Gross Margin (7.53%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BNXA has declined.
BNXA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.49%
GM growth 5Y-16.7%
BNXA.CA Yearly Profit, Operating, Gross MarginsBNXA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for BNXA remains at a similar level compared to 1 year ago.
BNXA has more shares outstanding than it did 5 years ago.
BNXA has a worse debt/assets ratio than last year.
BNXA.CA Yearly Shares OutstandingBNXA.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
BNXA.CA Yearly Total Debt VS Total AssetsBNXA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

BNXA has an Altman-Z score of 21.82. This indicates that BNXA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BNXA (21.82) is better than 96.55% of its industry peers.
BNXA has a debt to FCF ratio of 15.36. This is a negative value and a sign of low solvency as BNXA would need 15.36 years to pay back of all of its debts.
BNXA has a better Debt to FCF ratio (15.36) than 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.36
Altman-Z 21.82
ROIC/WACCN/A
WACCN/A
BNXA.CA Yearly LT Debt VS Equity VS FCFBNXA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.72 indicates that BNXA may have some problems paying its short term obligations.
BNXA has a better Current ratio (0.72) than 68.97% of its industry peers.
A Quick Ratio of 0.69 indicates that BNXA may have some problems paying its short term obligations.
The Quick ratio of BNXA (0.69) is better than 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.69
BNXA.CA Yearly Current Assets VS Current LiabilitesBNXA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.79% over the past year.
BNXA shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.14%.
BNXA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 109.35% yearly.
EPS 1Y (TTM)43.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)26.14%
Revenue growth 3Y91.18%
Revenue growth 5Y109.35%
Sales Q2Q%16.71%

3.2 Future

Based on estimates for the next years, BNXA will show a very negative growth in Earnings Per Share. The EPS will decrease by -24.56% on average per year.
BNXA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -57.73% yearly.
EPS Next Y57.14%
EPS Next 2Y-24.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.94%
Revenue Next 2Y-57.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BNXA.CA Yearly Revenue VS EstimatesBNXA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BNXA.CA Yearly EPS VS EstimatesBNXA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNXA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BNXA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNXA.CA Price Earnings VS Forward Price EarningsBNXA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

62.07% of the companies in the same industry are more expensive than BNXA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 63.9
EV/EBITDA N/A
BNXA.CA Per share dataBNXA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

BNXA's earnings are expected to decrease with -24.56% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.56%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BNXA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BANXA HOLDINGS INC

TSX-V:BNXA (9/5/2025, 7:00:00 PM)

1.22

-0.06 (-4.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)10-22 2025-10-22
Inst Owners0.06%
Inst Owner ChangeN/A
Ins Owners14.58%
Ins Owner ChangeN/A
Market Cap55.74M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-221.78%
Min EPS beat(2)-395.05%
Max EPS beat(2)-48.51%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)23.29%
Min Revenue beat(2)8.96%
Max Revenue beat(2)37.62%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 63.9
P/OCF 63.69
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)0.02
FCFY1.56%
OCF(TTM)0.02
OCFY1.57%
SpS7.19
BVpS-0.18
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.53%
FCFM 0.27%
ROA(3y)-66.12%
ROA(5y)-64.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.49%
GM growth 5Y-16.7%
F-Score4
Asset Turnover25.83
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.36
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.69
Altman-Z 21.82
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y57.14%
EPS Next 2Y-24.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.14%
Revenue growth 3Y91.18%
Revenue growth 5Y109.35%
Sales Q2Q%16.71%
Revenue Next Year6.94%
Revenue Next 2Y-57.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A